Aclaris Therapeutics, Inc. (ACRS)

3.205 -0.04 (-1.08%) USD  |  NASDAQ  |  Feb 23, 14:17
More

Aclaris Therapeutics Current Portion of Long Term Debt (Quarterly)

Current Portion of Long Term Debt (Quarterly) Chart

View Current Portion of Long Term Debt (Quarterly) for ACRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Portion of Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years

View Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Portion of Long Term Debt (Quarterly) Benchmarks

View Current Portion of Long Term Debt (Quarterly) Benchmarks
Start Trial
Oramed Pharmaceuticals, Inc. Upgrade
PMV Pharmaceuticals, Inc. Upgrade
Atea Pharmaceuticals, Inc. Upgrade
Instil Bio, Inc. Upgrade
Definium Therapeutics, Inc. Upgrade